老虎证券
Invest
Pricing
Rewards
Support
Learn
About
Quotes
TigerAI
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Prima BioMed Ltd
1.71
0.0000
成交量：
- -
成交额：
- -
市值：
3,525.34万
市盈率：
-0.81
高：
1.71
开：
1.71
低：
1.71
收：
1.71
52周最高：
3.26
52周最低：
1.40
股本：
2,061.60万
流通股本：
1,928.15万
量比：
- -
换手率：
- -
股息：
- -
股息率：
- -
每股收益(TTM):
-2.1000
净资产收益率：
--
总资产收益率：
--
市净率：
1.42
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻资讯
公告
公司资料
公司名字：
Prima BioMed Ltd
交易所：
NASDAQ
成立时间：
- -
员工人数：
- -
公司地址：
- -
官网：
http://www.primabiomed.com.au
邮编：
- -
电话：
- -
传真：
- -
简介：
Prima BioMed Ltd是根据澳大利亚联邦法律于1987年5月21日注册成立的，Prima BioMed有限公司是一家澳大利亚的生物技术公司，致力于个性化生物治疗产品，尤其专注于肿瘤学的发展。正在发展的关键候选产品是CVAC，这是基于自体树突细胞的产品，用于晚期卵巢上皮癌患者在第一行手术和化疗后，起到一个缓解的作用。
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎国际,美股交易,港股交易,交易美股,股票信息,股价,美股行情,美股打新,港股打新,IPO打新,购买美股,全球投资","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/PBMD/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"PBMD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBMD\",,,,,undefined,":{"symbol":"PBMD","market":"US","secType":"STK","nameCN":"Prima BioMed Ltd","latestPrice":1.71,"timestamp":1512162000000,"preClose":1.71,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":19281474,"shares":20616000,"eps":-2.1,"marketStatus":"退市","change":0,"latestTime":"12-01 16:00:00 EST","open":1.71,"high":1.71,"low":1.71,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.1,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":1,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.71,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBMD\",,,,,undefined,":{"symbol":"PBMD","floatShares":19281474,"roa":"--","roe":"--","lyrEps":0,"shares":20616000,"dividePrice":0,"high":1.71,"amplitude":0,"preClose":1.71,"low":1.71,"week52Low":1.4,"pbRate":"1.42","week52High":3.26,"institutionHeld":0,"latestPrice":1.71,"eps":-2.1,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.1,"open":1.71},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBMD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2016-09-05","symbol":"PBMD","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1473048000000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBMD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBMD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.primabiomed.com.au","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Prima BioMed Ltd是根据澳大利亚联邦法律于1987年5月21日注册成立的，Prima BioMed有限公司是一家澳大利亚的生物技术公司，致力于个性化生物治疗产品，尤其专注于肿瘤学的发展。正在发展的关键候选产品是CVAC，这是基于自体树突细胞的产品，用于晚期卵巢上皮癌患者在第一行手术和化疗后，起到一个缓解的作用。","exchange":"NASDAQ","name":"Prima BioMed Ltd","nameEN":"Prima Biomed"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PBMD\",market:\"US\",,,undefined,":null}}